Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 23, Issue 11, Pages 945-953
Publisher
Informa UK Limited
Online
2023-10-17
DOI
10.1080/14737175.2023.2265068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment
- (2023) Alisa R. Kosheleff et al. Journal of Attention Disorders
- Authors’ Reply to Pande et al. Comment on “Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder”
- (2023) Maxwell Z. Price et al. CNS DRUGS
- Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
- (2022) Lenard A. Adler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
- (2022) Azmi Nasser et al. CNS DRUGS
- Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
- (2021) Azmi Nasser et al. CLINICAL THERAPEUTICS
- Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults
- (2021) Shamia L. Faison et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder
- (2021) Stephen V. Faraone et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
- (2021) Robert L. Findling et al. CNS DRUGS
- A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder
- (2021) Azmi Nasser et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults
- (2021) Zhao Wang et al. Clinical Pharmacology in Drug Development
- Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD
- (2021) Margaret H. Sibley et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (QelbreeTM) in Healthy Adult Subjects
- (2021) Zhao Wang et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- A Phase III, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Once-Daily SPN-812 (Viloxazine Extended-Release) in the Treatment of Attention-Deficit/Hyperactivity Disorder in School-age Children
- (2020) Azmi Nasser et al. CLINICAL THERAPEUTICS
- Reduced striatal GABA in unmedicated children with ADHD at 7T
- (2020) Nicolaas A. Puts et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
- (2020) Shamia L. Faison et al. CLINICAL DRUG INVESTIGATION
- A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD
- (2019) Janet K. Johnson et al. Journal of Attention Disorders
- Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
- (2019) Sharon B. Wigal et al. Journal of Attention Disorders
- Koffein, das am häufigsten konsumierte Psychostimulans: eine narrative Übersichtsarbeit
- (2019) Maximilian Gahr FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood
- (2016) Marloes van Lieshout et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
- (2015) Kenneth S Koblan et al. NEUROPSYCHOPHARMACOLOGY
- Pozanicline for the treatment of attention-deficit/hyperactivity disorder
- (2014) Ann Childress et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Confirmatory Factor Analysis of the Behavior Rating Inventory of Executive Function-Adult Version in Healthy Adults and Application to Attention-Deficit/Hyperactivity Disorder
- (2013) R. M. Roth et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- THE EFFECTS OF CHILDHOOD ADHD ON ADULT LABOR MARKET OUTCOMES
- (2013) Jason M. Fletcher HEALTH ECONOMICS
- Efficacy of Metadoxine Extended Release in Patients With Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder
- (2013) Iris Manor et al. POSTGRADUATE MEDICINE
- A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment
- (2012) Monica Shaw et al. BMC Medicine
- Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States
- (2012) Jalpa A. Doshi et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
- (2012) Erik G. Willcutt Neurotherapeutics
- A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes
- (2010) Stephen V. Faraone et al. JOURNAL OF CLINICAL PSYCHIATRY
- Review of Medication Adherence in Children and Adults with ADHD
- (2010) Lisa D. Adler et al. POSTGRADUATE MEDICINE
- Validation of the Adult ADHD Investigator Symptom Rating Scale (AISRS)
- (2009) Thomas J. Spencer et al. Journal of Attention Disorders
- Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder
- (2009) Lenard A. Adler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started